In depth Analysis: Australian Federal Budget 2019 - 2020 - KWM

Current site :    AU   |   EN
China Hong Kong SAR
United Kingdom
United States

In-depth Analysis: Australian Federal Budget 2019 - 2020 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem fermentum, ullamcorper velit et, faucibus nisl. Phasellus efficitur neque et augue consectetur, sagittis aliquam nulla posuere. Phasellus et mollis est. Quisque imperdiet facilisis nibh, quis vehicula lacus malesuada ut. Sed hendrerit enim elit, in ultricies arcu blandit et. Duis efficitur erat vitae nisl faucibus, vitae suscipit est feugiat. Vivamus imperdiet sed erat ac bibendum. Pellentesque vulputate accumsan nisi nec bibendum. Etiam iaculis, purus non euismod faucibus, mauris leo ultrices elit, blandit vulputate erat risus sed dolor. Maecenas erat ligula, sodales quis lacinia ac, molestie id turpis. Maecenas et lorem feugiat, mattis sem sed, euismod metus. Cras turpis urna, ullamcorper nec nibh sed, porttitor dignissim elit. Aenean sed mollis neque, sed laoreet orci. Vivamus fermentum lacinia libero sed volutpat.

On 2 August 2022, the Aged Care and Other Legislation Amendment (Royal Commission Response) Bill 2022 was passed (Aged Care Bill), introducing important regulatory changes to Australia’s aged care sector. The Bill makes numerous legislative amendments, including to the Aged Care Act 1997 (Cth) (Aged Care Act) and the Aged Care (Transitional Provisions) Act 1997 (Cth) (Transitional Provisions Act), and responds to various recommendations made by the Royal Commission into Aged Care Quality and Safety (Royal Commission) Final Report (Report). The Report identified the provision of substandard aged care services and perceived systemic failures in the aged care sector.[1]

08 August 2022

The Federal Court has refused an application to stay proceedings to quantify compensation for patent infringement (quantum proceedings) pending the outcome of separate parallel proceedings challenging the validity of the infringed patent on new grounds. The case is significant as intellectual property cases are regularly bifurcated with liability determined separately damages or an account of profits. A patentee may also bring consecutive infringement cases and therefore have two separate cases considering invalidity issues for the same patent running in parallel.

03 August 2022

Since the introduction of a nationwide Marketing Authorization Holder (MAH) system in 2019, licenses have linked directly to therapeutic products rather than manufacturers.

03 August 2022